FDA Inspection
Huntsville Reproductive Medicine P.C.Huntsville Reproductive Medicine P.C. – FDA Inspection, Jul 12, 2018
Record Details
This FDA Inspection record concerns Huntsville Reproductive Medicine P.C., with an inspection on July 12, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 70493326-6797-4860-a64e-d359c5c502cb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1058611
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Huntsville Reproductive Medicine P.C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 5, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 22, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 2, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Huntsville Reproductive Medicine P.C.
- FDA Inspection 1187473 - 2022-10-26
- FDA Inspection 983625 - 2016-08-05
- FDA Inspection 820792 - 2013-02-22
- FDA Inspection 729969 - 2011-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.